Does DOXORUBICIN Cause T-cell lymphoma recurrent? 14 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 14 reports of T-cell lymphoma recurrent have been filed in association with DOXORUBICIN (Doxorubicin Hydrochloride). This represents 0.0% of all adverse event reports for DOXORUBICIN.
14
Reports of T-cell lymphoma recurrent with DOXORUBICIN
0.0%
of all DOXORUBICIN reports
1
Deaths
2
Hospitalizations
How Dangerous Is T-cell lymphoma recurrent From DOXORUBICIN?
Of the 14 reports, 1 (7.1%) resulted in death, 2 (14.3%) required hospitalization, and 2 (14.3%) were considered life-threatening.
Is T-cell lymphoma recurrent Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DOXORUBICIN. However, 14 reports have been filed with the FAERS database.
What Other Side Effects Does DOXORUBICIN Cause?
Febrile neutropenia (8,844)
Off label use (7,858)
Disease progression (6,165)
Neutropenia (5,891)
Drug ineffective (4,598)
Pyrexia (3,697)
Thrombocytopenia (3,638)
Anaemia (3,601)
Product use in unapproved indication (3,502)
Nausea (2,925)
What Other Drugs Cause T-cell lymphoma recurrent?
PREDNISONE (14)
VINCRISTINE (13)
ENDOXAN INJ (10)
RITUXIMAB (10)
SULFAMETHOXAZOLE (10)
TRIMETHOPRIM (10)
CYCLOPHOSPHAMIDE (5)
Which DOXORUBICIN Alternatives Have Lower T-cell lymphoma recurrent Risk?
DOXORUBICIN vs DOXYCYCLINE
DOXORUBICIN vs DOXYCYCLINE HYCLATE
DOXORUBICIN vs DOXYCYCLINE\DOXYCYCLINE HYCLATE
DOXORUBICIN vs DOXYLAMINE
DOXORUBICIN vs DOXYLAMINE\PYRIDOXINE